As we navigate the sophisticated scientific landscape of 2026, the global interest in lysergic acid diethylamide (LSD) has shifted from counter-cultural curiosity to rigorous clinical investigation. Researchers in the United States, Canada, and across the United Kingdom are increasingly seeking high-purity compounds to study the “Spirit Molecule” and its impact on neuroplasticity. When asking where […]